【市場調査レポート】核分子イメージングシステムのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Nuclear Molecular Imaging System Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。核分子イメージングシステムのグローバル市場インサイト・予測（～2028年） / Global Nuclear Molecular Imaging System Market Insights, Forecast to 2028 / QY2207E09894資料のイメージです。

• レポートコード：QY2207E09894
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の核分子イメージングシステムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に核分子イメージングシステムの世界市場のxxx％を占める「陽電子放射断層撮影」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「腫瘍」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の核分子イメージングシステムの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの核分子イメージングシステム市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの核分子イメージングシステム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

核分子イメージングシステムのグローバル主要メーカーには、Bruker、GE Healthcare、Siemens Healthcare、Philips Healthcare、Canon Medical Systems、Hitachi Medical、Digirad Corporation、DDD-Diagnostics A/S、Neusoft Medical Systems Co. Ltd.、Mediso Medical Imaging Systems, Ltd.、SurgicEye GmbH、CMR Naviscan Corporationなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

核分子イメージングシステム市場は、種類と用途によって区分されます。世界の核分子イメージングシステム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
陽電子放射断層撮影、単一光子放射型コンピューター断層撮影、平面シンチグラフィーシステム

【用途別セグメント】
腫瘍、心臓病、神経、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 核分子イメージングシステム製品概要
- 種類別市場（陽電子放射断層撮影、単一光子放射型コンピューター断層撮影、平面シンチグラフィーシステム）
- 用途別市場（腫瘍、心臓病、神経、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の核分子イメージングシステム販売量予測2017-2028
- 世界の核分子イメージングシステム売上予測2017-2028
- 核分子イメージングシステムの地域別販売量
- 核分子イメージングシステムの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別核分子イメージングシステム販売量
- 主要メーカー別核分子イメージングシステム売上
- 主要メーカー別核分子イメージングシステム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（陽電子放射断層撮影、単一光子放射型コンピューター断層撮影、平面シンチグラフィーシステム）
- 核分子イメージングシステムの種類別販売量
- 核分子イメージングシステムの種類別売上
- 核分子イメージングシステムの種類別価格
・用途別市場規模（腫瘍、心臓病、神経、その他）
- 核分子イメージングシステムの用途別販売量
- 核分子イメージングシステムの用途別売上
- 核分子イメージングシステムの用途別価格
・北米市場
- 北米の核分子イメージングシステム市場規模（種類別、用途別）
- 主要国別の核分子イメージングシステム市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの核分子イメージングシステム市場規模（種類別、用途別）
- 主要国別の核分子イメージングシステム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の核分子イメージングシステム市場規模（種類別、用途別）
- 主要国別の核分子イメージングシステム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の核分子イメージングシステム市場規模（種類別、用途別）
- 主要国別の核分子イメージングシステム市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの核分子イメージングシステム市場規模（種類別、用途別）
- 主要国別の核分子イメージングシステム市場規模（トルコ、サウジアラビア）
・企業情報
Bruker、GE Healthcare、Siemens Healthcare、Philips Healthcare、Canon Medical Systems、Hitachi Medical、Digirad Corporation、DDD-Diagnostics A/S、Neusoft Medical Systems Co. Ltd.、Mediso Medical Imaging Systems, Ltd.、SurgicEye GmbH、CMR Naviscan Corporation
・産業チェーン及び販売チャネル分析
- 核分子イメージングシステムの産業チェーン分析
- 核分子イメージングシステムの原材料
- 核分子イメージングシステムの生産プロセス
- 核分子イメージングシステムの販売及びマーケティング
- 核分子イメージングシステムの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 核分子イメージングシステムの産業動向
- 核分子イメージングシステムのマーケットドライバー
- 核分子イメージングシステムの課題
- 核分子イメージングシステムの阻害要因
・主な調査結果

Market Analysis and Insights: Global Nuclear Molecular Imaging System Market
Due to the COVID-19 pandemic, the global Nuclear Molecular Imaging System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Positron Emission Tomography accounting for % of the Nuclear Molecular Imaging System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Nuclear Molecular Imaging System market size is valued at US$ million in 2021, while the US and Europe Nuclear Molecular Imaging System are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nuclear Molecular Imaging System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Nuclear Molecular Imaging System include Bruker, GE Healthcare, Siemens Healthcare, Philips Healthcare, Canon Medical Systems, Hitachi Medical, Digirad Corporation, DDD-Diagnostics A/S and Neusoft Medical Systems Co. Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Nuclear Molecular Imaging System Scope and Segment
Nuclear Molecular Imaging System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nuclear Molecular Imaging System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Positron Emission Tomography
Single-photon Emission Computed Tomography
Planar Scintigraphy Systems
Segment by Application
Oncology
Cardiology
Neurology
Others
By Company
Bruker
GE Healthcare
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical
Digirad Corporation
DDD-Diagnostics A/S
Neusoft Medical Systems Co. Ltd.
Mediso Medical Imaging Systems, Ltd.
SurgicEye GmbH
CMR Naviscan Corporation
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Nuclear Molecular Imaging System Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Molecular Imaging System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Positron Emission Tomography
1.2.3 Single-photon Emission Computed Tomography
1.2.4 Planar Scintigraphy Systems
1.3 Market by Application
1.3.1 Global Nuclear Molecular Imaging System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nuclear Molecular Imaging System Sales Estimates and Forecasts 2017-2028
2.2 Global Nuclear Molecular Imaging System Revenue Estimates and Forecasts 2017-2028
2.3 Global Nuclear Molecular Imaging System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nuclear Molecular Imaging System Sales by Region
2.4.1 Global Nuclear Molecular Imaging System Sales by Region (2017-2022)
2.4.2 Global Sales Nuclear Molecular Imaging System by Region (2023-2028)
2.5 Global Nuclear Molecular Imaging System Revenue by Region
2.5.1 Global Nuclear Molecular Imaging System Revenue by Region (2017-2022)
2.5.2 Global Nuclear Molecular Imaging System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nuclear Molecular Imaging System Sales by Manufacturers
3.1.1 Global Top Nuclear Molecular Imaging System Manufacturers by Sales (2017-2022)
3.1.2 Global Nuclear Molecular Imaging System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nuclear Molecular Imaging System in 2021
3.2 Global Nuclear Molecular Imaging System Revenue by Manufacturers
3.2.1 Global Nuclear Molecular Imaging System Revenue by Manufacturers (2017-2022)
3.2.2 Global Nuclear Molecular Imaging System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nuclear Molecular Imaging System Revenue in 2021
3.3 Global Nuclear Molecular Imaging System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nuclear Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nuclear Molecular Imaging System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nuclear Molecular Imaging System Sales by Type
4.1.1 Global Nuclear Molecular Imaging System Historical Sales by Type (2017-2022)
4.1.2 Global Nuclear Molecular Imaging System Forecasted Sales by Type (2023-2028)
4.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Type (2017-2028)
4.2 Global Nuclear Molecular Imaging System Revenue by Type
4.2.1 Global Nuclear Molecular Imaging System Historical Revenue by Type (2017-2022)
4.2.2 Global Nuclear Molecular Imaging System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Type (2017-2028)
4.3 Global Nuclear Molecular Imaging System Price by Type
4.3.1 Global Nuclear Molecular Imaging System Price by Type (2017-2022)
4.3.2 Global Nuclear Molecular Imaging System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nuclear Molecular Imaging System Sales by Application
5.1.1 Global Nuclear Molecular Imaging System Historical Sales by Application (2017-2022)
5.1.2 Global Nuclear Molecular Imaging System Forecasted Sales by Application (2023-2028)
5.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Application (2017-2028)
5.2 Global Nuclear Molecular Imaging System Revenue by Application
5.2.1 Global Nuclear Molecular Imaging System Historical Revenue by Application (2017-2022)
5.2.2 Global Nuclear Molecular Imaging System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Application (2017-2028)
5.3 Global Nuclear Molecular Imaging System Price by Application
5.3.1 Global Nuclear Molecular Imaging System Price by Application (2017-2022)
5.3.2 Global Nuclear Molecular Imaging System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nuclear Molecular Imaging System Market Size by Type
6.1.1 North America Nuclear Molecular Imaging System Sales by Type (2017-2028)
6.1.2 North America Nuclear Molecular Imaging System Revenue by Type (2017-2028)
6.2 North America Nuclear Molecular Imaging System Market Size by Application
6.2.1 North America Nuclear Molecular Imaging System Sales by Application (2017-2028)
6.2.2 North America Nuclear Molecular Imaging System Revenue by Application (2017-2028)
6.3 North America Nuclear Molecular Imaging System Market Size by Country
6.3.1 North America Nuclear Molecular Imaging System Sales by Country (2017-2028)
6.3.2 North America Nuclear Molecular Imaging System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Nuclear Molecular Imaging System Market Size by Type
7.1.1 Europe Nuclear Molecular Imaging System Sales by Type (2017-2028)
7.1.2 Europe Nuclear Molecular Imaging System Revenue by Type (2017-2028)
7.2 Europe Nuclear Molecular Imaging System Market Size by Application
7.2.1 Europe Nuclear Molecular Imaging System Sales by Application (2017-2028)
7.2.2 Europe Nuclear Molecular Imaging System Revenue by Application (2017-2028)
7.3 Europe Nuclear Molecular Imaging System Market Size by Country
7.3.1 Europe Nuclear Molecular Imaging System Sales by Country (2017-2028)
7.3.2 Europe Nuclear Molecular Imaging System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nuclear Molecular Imaging System Market Size by Type
8.1.1 Asia Pacific Nuclear Molecular Imaging System Sales by Type (2017-2028)
8.1.2 Asia Pacific Nuclear Molecular Imaging System Revenue by Type (2017-2028)
8.2 Asia Pacific Nuclear Molecular Imaging System Market Size by Application
8.2.1 Asia Pacific Nuclear Molecular Imaging System Sales by Application (2017-2028)
8.2.2 Asia Pacific Nuclear Molecular Imaging System Revenue by Application (2017-2028)
8.3 Asia Pacific Nuclear Molecular Imaging System Market Size by Region
8.3.1 Asia Pacific Nuclear Molecular Imaging System Sales by Region (2017-2028)
8.3.2 Asia Pacific Nuclear Molecular Imaging System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Nuclear Molecular Imaging System Market Size by Type
9.1.1 Latin America Nuclear Molecular Imaging System Sales by Type (2017-2028)
9.1.2 Latin America Nuclear Molecular Imaging System Revenue by Type (2017-2028)
9.2 Latin America Nuclear Molecular Imaging System Market Size by Application
9.2.1 Latin America Nuclear Molecular Imaging System Sales by Application (2017-2028)
9.2.2 Latin America Nuclear Molecular Imaging System Revenue by Application (2017-2028)
9.3 Latin America Nuclear Molecular Imaging System Market Size by Country
9.3.1 Latin America Nuclear Molecular Imaging System Sales by Country (2017-2028)
9.3.2 Latin America Nuclear Molecular Imaging System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Nuclear Molecular Imaging System Market Size by Type
10.1.1 Middle East and Africa Nuclear Molecular Imaging System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nuclear Molecular Imaging System Revenue by Type (2017-2028)
10.2 Middle East and Africa Nuclear Molecular Imaging System Market Size by Application
10.2.1 Middle East and Africa Nuclear Molecular Imaging System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nuclear Molecular Imaging System Revenue by Application (2017-2028)
10.3 Middle East and Africa Nuclear Molecular Imaging System Market Size by Country
10.3.1 Middle East and Africa Nuclear Molecular Imaging System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nuclear Molecular Imaging System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bruker
11.1.1 Bruker Corporation Information
11.1.2 Bruker Overview
11.1.3 Bruker Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bruker Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bruker Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Corporation Information
11.2.2 GE Healthcare Overview
11.2.3 GE Healthcare Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GE Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GE Healthcare Recent Developments
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Corporation Information
11.3.2 Siemens Healthcare Overview
11.3.3 Siemens Healthcare Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Siemens Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Siemens Healthcare Recent Developments
11.4 Philips Healthcare
11.4.1 Philips Healthcare Corporation Information
11.4.2 Philips Healthcare Overview
11.4.3 Philips Healthcare Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Philips Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Philips Healthcare Recent Developments
11.5 Canon Medical Systems
11.5.1 Canon Medical Systems Corporation Information
11.5.2 Canon Medical Systems Overview
11.5.3 Canon Medical Systems Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Canon Medical Systems Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Canon Medical Systems Recent Developments
11.6 Hitachi Medical
11.6.1 Hitachi Medical Corporation Information
11.6.2 Hitachi Medical Overview
11.6.3 Hitachi Medical Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hitachi Medical Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hitachi Medical Recent Developments
11.7 Digirad Corporation
11.7.1 Digirad Corporation Corporation Information
11.7.2 Digirad Corporation Overview
11.7.3 Digirad Corporation Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Digirad Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Digirad Corporation Recent Developments
11.8 DDD-Diagnostics A/S
11.8.1 DDD-Diagnostics A/S Corporation Information
11.8.2 DDD-Diagnostics A/S Overview
11.8.3 DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 DDD-Diagnostics A/S Recent Developments
11.9 Neusoft Medical Systems Co. Ltd.
11.9.1 Neusoft Medical Systems Co. Ltd. Corporation Information
11.9.2 Neusoft Medical Systems Co. Ltd. Overview
11.9.3 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Neusoft Medical Systems Co. Ltd. Recent Developments
11.10 Mediso Medical Imaging Systems, Ltd.
11.10.1 Mediso Medical Imaging Systems, Ltd. Corporation Information
11.10.2 Mediso Medical Imaging Systems, Ltd. Overview
11.10.3 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mediso Medical Imaging Systems, Ltd. Recent Developments
11.11 SurgicEye GmbH
11.11.1 SurgicEye GmbH Corporation Information
11.11.2 SurgicEye GmbH Overview
11.11.3 SurgicEye GmbH Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 SurgicEye GmbH Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 SurgicEye GmbH Recent Developments
11.12 CMR Naviscan Corporation
11.12.1 CMR Naviscan Corporation Corporation Information
11.12.2 CMR Naviscan Corporation Overview
11.12.3 CMR Naviscan Corporation Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 CMR Naviscan Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CMR Naviscan Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nuclear Molecular Imaging System Industry Chain Analysis
12.2 Nuclear Molecular Imaging System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nuclear Molecular Imaging System Production Mode & Process
12.4 Nuclear Molecular Imaging System Sales and Marketing
12.4.1 Nuclear Molecular Imaging System Sales Channels
12.4.2 Nuclear Molecular Imaging System Distributors
12.5 Nuclear Molecular Imaging System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nuclear Molecular Imaging System Industry Trends
13.2 Nuclear Molecular Imaging System Market Drivers
13.3 Nuclear Molecular Imaging System Market Challenges
13.4 Nuclear Molecular Imaging System Market Restraints
14 Key Findings in The Global Nuclear Molecular Imaging System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Nuclear Molecular Imaging System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Positron Emission Tomography
Table 3. Major Manufacturers of Single-photon Emission Computed Tomography
Table 4. Major Manufacturers of Planar Scintigraphy Systems
Table 5. Global Nuclear Molecular Imaging System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Nuclear Molecular Imaging System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Nuclear Molecular Imaging System Sales by Region (2017-2022) & (K Units)
Table 8. Global Nuclear Molecular Imaging System Sales Market Share by Region (2017-2022)
Table 9. Global Nuclear Molecular Imaging System Sales by Region (2023-2028) & (K Units)
Table 10. Global Nuclear Molecular Imaging System Sales Market Share by Region (2023-2028)
Table 11. Global Nuclear Molecular Imaging System Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Nuclear Molecular Imaging System Revenue Market Share by Region (2017-2022)
Table 13. Global Nuclear Molecular Imaging System Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Nuclear Molecular Imaging System Revenue Market Share by Region (2023-2028)
Table 15. Global Nuclear Molecular Imaging System Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Nuclear Molecular Imaging System Sales Share by Manufacturers (2017-2022)
Table 17. Global Nuclear Molecular Imaging System Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Nuclear Molecular Imaging System Revenue Share by Manufacturers (2017-2022)
Table 19. Nuclear Molecular Imaging System Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Nuclear Molecular Imaging System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Nuclear Molecular Imaging System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Molecular Imaging System as of 2021)
Table 22. Nuclear Molecular Imaging System Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Nuclear Molecular Imaging System Product Offered
Table 24. Date of Manufacturers Enter into Nuclear Molecular Imaging System Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 27. Global Nuclear Molecular Imaging System Sales by Type (2023-2028) & (K Units)
Table 28. Global Nuclear Molecular Imaging System Sales Share by Type (2017-2022)
Table 29. Global Nuclear Molecular Imaging System Sales Share by Type (2023-2028)
Table 30. Global Nuclear Molecular Imaging System Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Nuclear Molecular Imaging System Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Nuclear Molecular Imaging System Revenue Share by Type (2017-2022)
Table 33. Global Nuclear Molecular Imaging System Revenue Share by Type (2023-2028)
Table 34. Nuclear Molecular Imaging System Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Nuclear Molecular Imaging System Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 37. Global Nuclear Molecular Imaging System Sales by Application (2023-2028) & (K Units)
Table 38. Global Nuclear Molecular Imaging System Sales Share by Application (2017-2022)
Table 39. Global Nuclear Molecular Imaging System Sales Share by Application (2023-2028)
Table 40. Global Nuclear Molecular Imaging System Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Nuclear Molecular Imaging System Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Nuclear Molecular Imaging System Revenue Share by Application (2017-2022)
Table 43. Global Nuclear Molecular Imaging System Revenue Share by Application (2023-2028)
Table 44. Nuclear Molecular Imaging System Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Nuclear Molecular Imaging System Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 47. North America Nuclear Molecular Imaging System Sales by Type (2023-2028) & (K Units)
Table 48. North America Nuclear Molecular Imaging System Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Nuclear Molecular Imaging System Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 51. North America Nuclear Molecular Imaging System Sales by Application (2023-2028) & (K Units)
Table 52. North America Nuclear Molecular Imaging System Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Nuclear Molecular Imaging System Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Nuclear Molecular Imaging System Sales by Country (2017-2022) & (K Units)
Table 55. North America Nuclear Molecular Imaging System Sales by Country (2023-2028) & (K Units)
Table 56. North America Nuclear Molecular Imaging System Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Nuclear Molecular Imaging System Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 59. Europe Nuclear Molecular Imaging System Sales by Type (2023-2028) & (K Units)
Table 60. Europe Nuclear Molecular Imaging System Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Nuclear Molecular Imaging System Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 63. Europe Nuclear Molecular Imaging System Sales by Application (2023-2028) & (K Units)
Table 64. Europe Nuclear Molecular Imaging System Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Nuclear Molecular Imaging System Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Nuclear Molecular Imaging System Sales by Country (2017-2022) & (K Units)
Table 67. Europe Nuclear Molecular Imaging System Sales by Country (2023-2028) & (K Units)
Table 68. Europe Nuclear Molecular Imaging System Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Nuclear Molecular Imaging System Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Nuclear Molecular Imaging System Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Nuclear Molecular Imaging System Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Nuclear Molecular Imaging System Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Nuclear Molecular Imaging System Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Nuclear Molecular Imaging System Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Nuclear Molecular Imaging System Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Nuclear Molecular Imaging System Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Nuclear Molecular Imaging System Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Nuclear Molecular Imaging System Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Nuclear Molecular Imaging System Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Nuclear Molecular Imaging System Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Nuclear Molecular Imaging System Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Nuclear Molecular Imaging System Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Nuclear Molecular Imaging System Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Nuclear Molecular Imaging System Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Nuclear Molecular Imaging System Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Nuclear Molecular Imaging System Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Nuclear Molecular Imaging System Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Nuclear Molecular Imaging System Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Nuclear Molecular Imaging System Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Nuclear Molecular Imaging System Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Nuclear Molecular Imaging System Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Nuclear Molecular Imaging System Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Nuclear Molecular Imaging System Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Nuclear Molecular Imaging System Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Nuclear Molecular Imaging System Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Nuclear Molecular Imaging System Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Nuclear Molecular Imaging System Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Nuclear Molecular Imaging System Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Nuclear Molecular Imaging System Revenue by Country (2023-2028) & (US$ Million)
Table 106. Bruker Corporation Information
Table 107. Bruker Description and Major Businesses
Table 108. Bruker Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Bruker Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Bruker Recent Developments
Table 111. GE Healthcare Corporation Information
Table 112. GE Healthcare Description and Major Businesses
Table 113. GE Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. GE Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. GE Healthcare Recent Developments
Table 116. Siemens Healthcare Corporation Information
Table 117. Siemens Healthcare Description and Major Businesses
Table 118. Siemens Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Siemens Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Siemens Healthcare Recent Developments
Table 121. Philips Healthcare Corporation Information
Table 122. Philips Healthcare Description and Major Businesses
Table 123. Philips Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Philips Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Philips Healthcare Recent Developments
Table 126. Canon Medical Systems Corporation Information
Table 127. Canon Medical Systems Description and Major Businesses
Table 128. Canon Medical Systems Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Canon Medical Systems Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Canon Medical Systems Recent Developments
Table 131. Hitachi Medical Corporation Information
Table 132. Hitachi Medical Description and Major Businesses
Table 133. Hitachi Medical Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Hitachi Medical Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Hitachi Medical Recent Developments
Table 136. Digirad Corporation Corporation Information
Table 137. Digirad Corporation Description and Major Businesses
Table 138. Digirad Corporation Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Digirad Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Digirad Corporation Recent Developments
Table 141. DDD-Diagnostics A/S Corporation Information
Table 142. DDD-Diagnostics A/S Description and Major Businesses
Table 143. DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. DDD-Diagnostics A/S Recent Developments
Table 146. Neusoft Medical Systems Co. Ltd. Corporation Information
Table 147. Neusoft Medical Systems Co. Ltd. Description and Major Businesses
Table 148. Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Neusoft Medical Systems Co. Ltd. Recent Developments
Table 151. Mediso Medical Imaging Systems, Ltd. Corporation Information
Table 152. Mediso Medical Imaging Systems, Ltd. Description and Major Businesses
Table 153. Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Mediso Medical Imaging Systems, Ltd. Recent Developments
Table 156. SurgicEye GmbH Corporation Information
Table 157. SurgicEye GmbH Description and Major Businesses
Table 158. SurgicEye GmbH Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. SurgicEye GmbH Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. SurgicEye GmbH Recent Developments
Table 161. CMR Naviscan Corporation Corporation Information
Table 162. CMR Naviscan Corporation Description and Major Businesses
Table 163. CMR Naviscan Corporation Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. CMR Naviscan Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. CMR Naviscan Corporation Recent Developments
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Nuclear Molecular Imaging System Distributors List
Table 169. Nuclear Molecular Imaging System Customers List
Table 170. Nuclear Molecular Imaging System Market Trends
Table 171. Nuclear Molecular Imaging System Market Drivers
Table 172. Nuclear Molecular Imaging System Market Challenges
Table 173. Nuclear Molecular Imaging System Market Restraints
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Molecular Imaging System Product Picture
Figure 3. Global Nuclear Molecular Imaging System Market Share by Type in 2021 & 2028
Figure 3. Positron Emission Tomography Product Picture
Figure 4. Single-photon Emission Computed Tomography Product Picture
Figure 5. Planar Scintigraphy Systems Product Picture
Figure 6. Global Nuclear Molecular Imaging System Market Share by Application in 2021 & 2028
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Neurology
Figure 10. Others
Figure 11. Nuclear Molecular Imaging System Report Years Considered
Figure 12. Global Nuclear Molecular Imaging System Sales 2017-2028 (K Units)
Figure 13. Global Nuclear Molecular Imaging System Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Nuclear Molecular Imaging System Revenue 2017-2028 (US$ Million)
Figure 15. Global Nuclear Molecular Imaging System Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Nuclear Molecular Imaging System Sales Market Share by Region (2017-2022)
Figure 17. Global Nuclear Molecular Imaging System Sales Market Share by Region (2023-2028)
Figure 18. North America Nuclear Molecular Imaging System Sales YoY (2017-2028) & (K Units)
Figure 19. North America Nuclear Molecular Imaging System Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Nuclear Molecular Imaging System Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Nuclear Molecular Imaging System Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Nuclear Molecular Imaging System Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Nuclear Molecular Imaging System Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Nuclear Molecular Imaging System Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Nuclear Molecular Imaging System Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Nuclear Molecular Imaging System Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Nuclear Molecular Imaging System Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Nuclear Molecular Imaging System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Nuclear Molecular Imaging System in the World: Market Share by Nuclear Molecular Imaging System Revenue in 2021
Figure 30. Global Nuclear Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Nuclear Molecular Imaging System Sales Market Share by Type (2017-2028)
Figure 32. Global Nuclear Molecular Imaging System Revenue Market Share by Type (2017-2028)
Figure 33. Global Nuclear Molecular Imaging System Sales Market Share by Application (2017-2028)
Figure 34. Global Nuclear Molecular Imaging System Revenue Market Share by Application (2017-2028)
Figure 35. North America Nuclear Molecular Imaging System Sales Market Share by Type (2017-2028)
Figure 36. North America Nuclear Molecular Imaging System Revenue Market Share by Type (2017-2028)
Figure 37. North America Nuclear Molecular Imaging System Sales Market Share by Application (2017-2028)
Figure 38. North America Nuclear Molecular Imaging System Revenue Market Share by Application (2017-2028)
Figure 39. North America Nuclear Molecular Imaging System Sales Share by Country (2017-2028)
Figure 40. North America Nuclear Molecular Imaging System Revenue Share by Country (2017-2028)
Figure 41. United States Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Nuclear Molecular Imaging System Sales Market Share by Type (2017-2028)
Figure 44. Europe Nuclear Molecular Imaging System Revenue Market Share by Type (2017-2028)
Figure 45. Europe Nuclear Molecular Imaging System Sales Market Share by Application (2017-2028)
Figure 46. Europe Nuclear Molecular Imaging System Revenue Market Share by Application (2017-2028)
Figure 47. Europe Nuclear Molecular Imaging System Sales Share by Country (2017-2028)
Figure 48. Europe Nuclear Molecular Imaging System Revenue Share by Country (2017-2028)
Figure 49. Germany Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 50. France Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Nuclear Molecular Imaging System Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Nuclear Molecular Imaging System Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Nuclear Molecular Imaging System Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Nuclear Molecular Imaging System Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Nuclear Molecular Imaging System Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Nuclear Molecular Imaging System Revenue Share by Region (2017-2028)
Figure 60. China Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 63. India Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Nuclear Molecular Imaging System Sales Market Share by Type (2017-2028)
Figure 70. Latin America Nuclear Molecular Imaging System Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Nuclear Molecular Imaging System Sales Market Share by Application (2017-2028)
Figure 72. Latin America Nuclear Molecular Imaging System Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Nuclear Molecular Imaging System Sales Share by Country (2017-2028)
Figure 74. Latin America Nuclear Molecular Imaging System Revenue Share by Country (2017-2028)
Figure 75. Mexico Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 78. Colombia Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Nuclear Molecular Imaging System Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Nuclear Molecular Imaging System Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Nuclear Molecular Imaging System Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Nuclear Molecular Imaging System Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Nuclear Molecular Imaging System Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Nuclear Molecular Imaging System Revenue Share by Country (2017-2028)
Figure 85. Turkey Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Nuclear Molecular Imaging System Revenue (2017-2028) & (US$ Million)
Figure 88. Nuclear Molecular Imaging System Value Chain
Figure 89. Nuclear Molecular Imaging System Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

以下、関連資料のご紹介

眼科超音波画像システムのグローバル市場インサイト・予測（～2028年）

Global Ophthalmic Ultrasound Imaging System Market Insights, Forecast to 2028
QY2207E09909 2022年7月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の眼科超音波画像システムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼科超音波画像...

精密がん画像システムのグローバル市場インサイト・予測（～2028年）

Global Precision Cancer Imaging System Market Insights, Forecast to 2028
QY2207E10018 2022年7月 96Pages
新型コロナウイルス感染症のパンデミックにより、世界の精密がん画像システムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に精密がん画像シス...

世界の近赤外線医療用蛍光イメージングシステム市場予測（～2028年）：開腹手術、腹腔鏡手術

Global Near Infrared Medical Fluorescence Imaging System Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8199 2022年5月 107Pages
近赤外線医療用蛍光イメージングシステム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関す...

手術用蛍光イメージング装置のグローバル市場インサイト・予測（～2028年）

Global Surgical Fluorescence Imaging System Market Insights, Forecast to 2028
QY2207E10142 2022年7月 105Pages
新型コロナウイルス感染症のパンデミックにより、世界の手術用蛍光イメージング装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に手術用蛍光...

細胞画像分析システムのグローバル市場インサイト・予測（～2028年）

Global Cell Imaging Analysis Systems Market Insights, Forecast to 2028
QY2207C3670 2022年7月11日 111Pages
新型コロナウイルス感染症のパンデミックにより、世界の細胞画像分析システムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に細胞画像分析シス...

ハイブリッド陽電子放出断層撮影（PET）システムのグローバル市場インサイト・予測（～2028年） The fusing of two or more imaging technologies into a single new form is known as hybrid imaging. When compared to two single photos, the image created with the hybrid imaging system is more powerful in terms of accuracy. Hybrid imaging, in addition to portraying anatomy, allows for in vivo viewing …
マイクロコンピューター断層撮影システムのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Micro-Computed Tomography System Market Due to the COVID-19 pandemic, the global Micro-Computed Tomography System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the fore…
世界のバイオ医薬品用前臨床断層撮影システム市場予測（～2028年）：CT、SPECT、その他 The Preclinical Tomography System for Biopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
精密がん画像システムのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Precision Cancer Imaging System Market Due to the COVID-19 pandemic, the global Precision Cancer Imaging System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the foreca…
細胞画像分析システムのグローバル市場インサイト・予測（～2028年） The Use of Dynamic Live Cell Methods Allows Visualization of Structure, Behavior or Composition in Living Cells Without the Need for Traditional Staining. These Techniques Are Well Suited for Applications Where in Vivo Conditions Must Be Simulated and for the Development of Predictive Assays for Dru…